# Impact of Aminoglycosides in Hypotensive Septic Oncology Patients

> **NCT05045963** · — · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 232 (actual)

## Conditions studied

- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Septicemia

## Interventions

- **OTHER:** Electronic Health Record Review

## Key facts

- **NCT ID:** NCT05045963
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-04
- **Primary completion:** 2026-02-13
- **Final completion:** 2026-02-13
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05045963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05045963, "Impact of Aminoglycosides in Hypotensive Septic Oncology Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05045963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*